AbCellera Biologics Inc. - 10-Q Filing
AbCellera Biologics Inc. reports financial results for the quarterly period ended September 30, 2026.
Tickers: $ABCL
Read the full article at SEC EDGAR
Part of the story Pasqal Holding SA Reports Q3 Revenue of €3.3 Million and Strong Booked Business (4 articles)